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The aim of this work was to evaluate the influence of maternal and embryonic 
genotype on prenatal survival and fetal growth during pregnancy. Embryos 
were recovered at 48 h of gestation from two different donor lines (R=46 and 
A=40) and transferred to nulliparous recipient does (26 R and 24 A). Each 
recipient doe received six embryos into one oviduct from line R and six embryos 
form line A into the other. Laparoscopy was performed at day 14 to determine 
implantation rate. Recipient females were slaughter at day 14, 24 and 30 (12, 
24, 14, respectively) to determine the number of live foetuses and the weight of 
live foetuses, fetal placenta and maternal placenta. A transcriptome analysis 
was performed to search for differences between fetal placentas at day 14 
and 24 of development. Prenatal survival at Days 14 and 24 was affected by 
embryonic genotype and determined by maternal genotype at Day 30. Fetal 
weight at Day 14 was influenced by both genotypes, being the weight higher 
for group A/A (0.29±0.01 g vs. 0.19±0.01 g, for group R/R). However, both 
genotypes were determinant for fetal placenta weight at Day 24, while those 
genotypes affected maternal placenta weight at Day 30. Nevertheless, no 
differences in fetal placenta at transcriptome level and progesterone and IGF-I 
plasma levels in recipient does were found. In conclusion, results indicate that 
the influence of embryo and maternal genotype on the prenatal survival and 











Embryo development and survival, as well as a successful pregnancy, are 
dependent on a well-established and functional placenta. Yet the influence of 
embryonic and maternal genotypes on placental weight is controversial. While 
both genotypes had an influence on fetal and placenta weight in mouse and 
pig (Al-Murrani and Roberts, 1978; Barkley and Fitzgerald, 1990; Biensen et al., 
1998; Wilson et al., 1998), Mocé et al. (2004a) stated that fetal weight in the last 
term of gestation depends on the maternal genotype, and fetal-placental 
weight depends on the embryonic genotype in rabbit. However, recently 
Vicente et al. (2013) showed that embryonic genotype affects fetal weight, but 
both embryonic and maternal genotype affect fetal-placental weight in the 
last term of gestation. In fact, fetal growth in late gestation is dependent upon 
the correct growth and development of the placenta (Chaddha et al., 2004).  
The establishment of a healthy and functional placenta is a crucial element in 
the embryonic and fetal development. The development and interrelationships 
between maternal and fetal vascular networks in the placenta is critical for the 
successful development of the offspring (Yllera et al., 2003).  
Therefore, due to the relevant role of the placenta and the fetal-placental 
interface, several works have focused in the study of placenta transcriptome 
(Buffat et al., 2007; Zhou et al., 2009; Salilew-Wondim et al., 2013; Whitehead et 
al., 2013; Gu et al., 2014). The advantage of microarray analysis is the 
simultaneous measurement of the expression patterns of large numbers of 
genes (Lockhart et al., 1996). These studies showed differences at 
transcriptomic level between porcine placentas with different placental 





restriction and fetal growth restriction (Buffat et al., 2007; Whitehead et al., 
2013), and between bovine placentas derived from artificial insemination, in 
vitro fertilization and somatic cell nuclear transfer (Salilew-Wondim et al., 2013). 
  
In this work, we set out to evaluate the effect of maternal and embryonic 
genotype on prenatal survival and placenta and fetal weights over the course 
of pregnancy. In addition, fetal placenta transcriptome at Days 14 and 24 of 
pregnancy was addressed. 
 
MATERIAL AND METHODS 
All chemicals in this study were purchased form Sigma-Aldrich Química S.A. 
(Madrid, Spain) unless stated otherwise. 
1. Ethical Statement 
The Ethics and Animal Welfare Committee of the Polytechnic University of 
Valencia approved this study. All animals were handled according to the 
principles of animal care published by Spanish Royal Decree 53/2013. 
2. Animals 
Animals used as donors and recipients came from two commercial lines 
generated at the Universidad Politécnica de Valencia. One (named line R) is a 
synthetic line selected since 1990 by individual selection on daily weight gain 
from weaning to slaughter age (28 and 63 days, Estany et al., 1992) and the 
other one (named line A) came form a New Zealand White selected since 1980 
by a family index for litter size at weaning (Estany et al., 1989). Animals were 
kept under controlled (16 h light : 8 h dark) photoperiod and fed with a 





extract, 16.7% crude fiber, 2938 kcal/kg).  
3. Embryo transfer 
The scheme for the embryo transfer procedure is presented in Figure 1.1. At the 
age of five months, a total of 86 nulliparous does were used as donor females; 
46 does from the line R and 40 does from the line A. Does were injected 25 IU of 
eCG intramuscular (Intervet International B.V., Bowmeer-Holland) to induce 
receptivity. After 48 hours, females were artificially inseminated with a 
heterospermic pool of fertile males from the same selected line to randomise 
male effect. At the time of artificial insemination, females were injected with 1 
µg of buserelin acetate (Hoechst, Marion Roussel, Madrid, Spain) to induce 
ovulation. Then, does were slaughtered 48 hours after insemination. Embryos 
were collected at room temperature by flushing the oviducts and the first one-
third of the uterine horns with 5 mL of embryo recovery media consisting of 
Dulbecco’s Phosphate-Buffered Saline (DPBS) supplemented with 0.2% (w/v) 
bovine serum albumin (BSA) and antibiotics (penicillin G sodium 300,000 IU, 
penicillin G procaine 700,000 IU, and dihydrostreptomycin sulphate 1250 mg; 
Penivet 1; Divasa Farmavic, Barcelona, Spain). After recovery, morphologically 
normal embryos (classified as normal when they presented correct 
developmental stage, homogeneous cell size and cytoplasm aspect, and 
spherical zona pellucida and mucin coat) were kept at room temperature (20-
25ºC) in dark light until transfer to recipient females.  
A total of 600 embryos were transferred. Receptive females (according to the 
turgidity and colour of the vulva) were induced to ovulate by injection of 1 µg 
of buserelin acetate (Hoechst, Marion Roussel, Madrid, Spain) 48 hours before 





xylazine (Rompún, Bayer AG, Leverkusen, Germany) following intravenous 
injection of 15 mg/kg ketamine hydrochloride (Imalgène, Merial SA, Lyon, 
France). Embryo transfer was performed using the laparoscopic technique 
described by Besenfelder and Brem (1993). At the age of 5 months, a total of 26 
nulliparous females from line R and 24 from line A were used. The number of 
embryos transferred per oviduct was standardised to 6, so that all recipients 
received 12 embryos (six embryos from line R into one oviduct and six embryos 
from line A into the other). Transfers to right or left uterine horns were 
randomised. According to the transfers, four groups were obtained: 
R[embryo]/R[mother] (R/R), R[embryo]/A[mother] (R/A), A[embryo]/A[mother] (A/A), and 
A[embryo]/R[mother] (A/R). 
 
Figure 1.1. Schematic illustration of the embryo transfer model used in this study to 
determine maternal genotype and fetal genotype effect on prenatal survival and fetal 
growth. A/ R (A) embryo transferred into R foster mother; R/R (R) embryo transferred into 
R foster mother; R/A (R) embryo transferred into A foster mother; A/A (A) embryo 
transferred into A foster mother. Transferred embryos were gestated in foster mothers for 







4. Prenatal survival rate and samples at Day 14, 24 and 30  
Implantation rate in each horn (number of implanted embryos at Day 14 from 
total embryos transferred) was assessed by laparoscopy, according to the 
procedure previously described (Llobat et al., 2012; Vicente et al., 2012). 
Recipient females were sequentially euthanized at Day 14 (n=12), Day 24 
(n=24) and Day 30 (n=14). Then, prenatal survival was assessed, and live 
foetuses were weighted after placental membranes and fluids were removed. 
Fetal placenta and adjacent maternal placenta from each foetus were 
dissected separately and individually weighted. Samples from fetal placental 
tissue were stored for RNA expression analysis at -80ºC.  
 
5. RNA Extraction 
PolyA RNA was extracted from fetal placental tissue at Day 14 and Day 24 of 
group RR and group AA. 
In the case of Day 14 fetal placentas, total RNA was isolated from 10 samples 
per experimental group. In the case of Day 24 fetal placentas, seven samples 
per experimental group were used. A traditional phenol/chloroform extraction 
by sonication in the Trizol reagent was performed. Then, RNA was purified by 
RNA Clean-up columns (Nucleospin, Madrid, Spain), and concentration, quality 
and integrity of RNA were evaluated by Nanodrop 1000 and Bioanalyzer 2100 






6. Microarray analysis 
For the two-colour microarray analysis, four biological replicates were used Day 
14 fetal placentas, including two dye swaps to compensate dye-bias. For Day 
24, four biological replicates were used including one dye-swap. 
Total RNA (100 ng) was amplified using QuickAmp Labelling Kit (Agilent 
Technologies, Madrid, Spain), following manufacturer's instructions. The 
complementary RNA (cRNA) generated was purified and labelled with 
Cyanine 3 dye (Cy3) and Cyanine 5 dye (Cy5). Excess dye was removed with 
the QIAquick PCR purification kit (Qiagen Iberia S.L, Madrid, Spain) and dye 
incorporation and concentration were determined using the microarray setting 
on the Nanodrop 1000.  Equal amounts of Cy3 and Cy5 labelled samples (825 
ng) were mixed with 10X Blocking Agent and Fragmentation Buffer, and then 55 
µL of the mixture were hybridised into the Rabbit 44X oligonucleotide array 
G2519F (Agilent Technologies, Madrid, Spain).  After 17 hours at 65ºC, hybridised 
slides were washed and scanned using the Agilent DNA Microarray Scanner 
G2565B (Agilent Technologies, Madrid, Spain). The resulting images were 
processed using Feature Extraction v.10 Software (Agilent Technologies, Madrid, 
Spain) with default parameters. Normalization with the locally weighted linear 
regression (LOWESS) algorithm and identification of differentially expressed 
transcripts was achieved using the Limma package in R (www.r-project.org). P-
values were adjusted for multiple testing using the Benjamini and Hochberg 
false discovery rate (FDR), and differences of P<0.05 were considered 
significant. All data sets related to this study were deposited in NCBI's Gene 








To validate the microarray results RT-PCR for six genes (VEGF, ERBB3, TGFB2, 
IGF1, ITGA1, INFG) were carried out in 20 independent samples for Day 14 fetal 
placentas and 14 samples Day 24 fetal placenta. To prevent DNA 
contamination, one deoxyribonuclease treatment step (gDNA Wipeout Buffer, 
Qiagen Iberia S.L, Madrid, Spain) was performed from total RNA (1000 ng). 
Afterwards, reverse transcription was carried out using Reverse Transcriptase 
Quantitect kit (Qiagen Iberia S.L, Madrid, Spain) according to the 
manufacturer’s instructions. Real-time PCR reactions were conducted in an 
Applied Biosystems 7500 (Applied Biosystems, Foster City, CA). Every PCR was 
performed from 5 µL diluted 1:20 cDNA template, 250 nM of forward and 
reverse primers (Table 1.1) and 10 µL of PowerSYBR Green PCR Master Mix 
(Fermentas GMBH, Madrid, Spain) in a final volume of 20 µL. The PCR protocol 
included an initial step of 50ºC (2 min), followed by 95ºC (10 min) and 40 cycles 
of 95ºC (15s) and 60ºC (60s). After real-time PCR, a melting curve analysis was 
performed by slowly increasing the temperature from 65ºC to 95ºC, with a 
continuous registration of changes in fluorescent emission intensity. The 
products of RT-PCR were confirmed by bromure ethide-stained 2% agarose gel 
electrophoresis in 1x Bionic buffer (Sigma Aldrich Química S.A, Alcobendas, 
Madrid, Spain). Serial dilutions of cDNA pool made from several samples were 
done to assess PCR efficiency.  A ΔΔCt method adjusted for PCR efficiency was 
used, employing the geometric average of H2AFZ (H2A histone family member 
Z) and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) as 
housekeeping normalization factor (Weltzien et al., 2005). Relative expression of 
cDNA pool from various samples was used as the calibrator to normalize all 





8. Progesterone and  IGF I serum levels 
Whole blood was collected from 14 females at Day 14, 21 and 28 of gestation 
with the aid of a Vacutainer-heparin tube (LH/Li Heparin Tube TAPVAL®, 
MonLab, SL. Barcelona, Spain).  Blood was centrifuged (1500 x g, 10 min at 4ºC) 
and plasma was stored at -80ºC until assaying.  Plasma levels of progesterone 
(steroid C21, preg-4-ene-3,20-dione) and Insulin-like Growth Factor-I (IGF-I) were 
determined by direct enzyme immunoassay technique following the 
manufacturer’s instructions (Rabbit Progesterone Elisa Test, Endocrine 
Technologies, Inc. Newark, USA; IGF-I Elisa Kit, Diagnostic Systems Laboratories, 
Inc. Texas, USA) . Sensitivities of the tests used were 0.1 ηg/mL mL for 





Table 1.1. Primers sequence, accession number, amplicon size obtained, efficiency, correlation and reference where indicated, of 
genes analyzed and housekeeping genes used (VEGF, as Vascular Endothelial Growth Factor; ERBB3, as Epidermal Growth Factor 
Receptor 3; TGFB2, as Trasnforming Growth  Factor β2; IGF1, as Insulin-like Growth Factor-I; ITGA1: Integrin alfa-1; INFG: as Interferon 
Gamma; Histone (H2afz) and GAPDH, as housekeeping gene. 








VEGF AY196796 For - 5’ CTACCTCCACCATGCCAAGT 
Rev - 5’ CACACTCCAGGCTTTCATCA 
236 95.5 0.99 Saenz-de-Juano et al. 2011b 
ERBB3 AF333179 
For - 5’ GTCACATGGACACGATCGAC 
Rev - 5’ AAGCAGTGGCCGTTACACT 
191 96 0.98 Saenz-de-Juano et al. 2011a 
TGFB2 NM_001082660 
For - 5’ GACCCCACATCTCCTGCTAA 
Rev - 5’ CACCCAAGATCCCTCTTGAA 
165 98 0.95 Saenz-de-Juano et al. 2011a 
IGF1 ENSOCUT00000014681 
For - 5’ GTGGATGCTCTTCAGTTCGT 
Rev - 5’ CAGCCTCCTCAGATCACAG 





81 100.0 0.99 Saenz-de-Juano et al.2012 
INFG NM_001081991 
For-5’ GTCTGCATTCTAGCCACTG  
Rev-5’ ATTCAGGGGCAGTCACAGTT 
151 100.5 0.99 Llobat et al. 2012 
 H2afz AF030235 
For  - 5’ AGAGCCGGCTGCCAGTTCC 
Rev - 5’ CAGTCGCGCCCACACGTCC 
85 99.5 0.99 







For- 5’ GCCGCTTCTTCTCGTGCAG 
Rev-5’ ATGGATCATTGATGGCGACAACAT 





9. Statistical analysis 
All traits were analysed by a generalised linear model (GLM), using the SPSS 
software package, version 16.0 (SPSS Inc, Chicago Illinois, USA 2002). Results are 
reported as least square means ± SEM. Means were considered statistically 
different at P≤ 0.05.  
A probit link function was used to determine the effect of maternal and 
embryonic genotypes on implantation rate and fetal survival at Day 14 and 24 
and 30 of gestation, respectively. The GLM fitted to analyse these traits 
included as fixed effects the embryonic genotype (R or A), maternal genotype 
(R or A) and their interactions (groups RR, RA, AR, AA). Number of implanted 
embryos at Day 14 per recipient was included as a covariate in the analysis of 
fetal survival at Day 24 and 30. 
To analyse the fetal and placental (foetus and maternal) weights were 
analyzed with a GLM including as fixed factors maternal genotype (R or A), 
gestation day (14, 24, 30) and their interaction was used. Progesterone and IGF-
I plasma levels, were also analyzed with a GLM including as fixed factors 
maternal genotype (R or A), gestation day (14, 21, 28) and their interaction. 
Moreover, placenta and fetal weights were analysed including the current 
number of live foetuses at Day 14, 24 and 30 of gestation as covariate.  
Data of relative mRNA abundance were normalised by a Nepierian logarithm 









1. Prenatal survival rate 
Prenatal survival rate was affected by embryonic genotype at Day 14 and 24 
but not at Day 30. The total implantation rate at Day 14 was 0.75 ± 0.04 of total 
transferred embryos (447/600). The implantation rate was lower for embryonic 
genotype R (0.57± 0.04 and 0.69 ± 0.04, for genotype R and A, respectively, 




Figure 1.2. Prenatal survival at Day 14, 24 and 30 for the different lines. A: Fetal 
survival for the embryonic genotype effect; B: Fetal survival for the maternal 








Nevertheless, when the number of implanted embryos at Day 24 was included 
as a covariate, a significant interaction between both genotypes was 
observed. Concretely, group R/R presented lower live fetuses rate (0.48 ± 0.05 
vs. 0.68 ± 0.04, 0.60 ± 0.05, 0.70 ± 0.05, for genotypes interaction A/A, A/R and 
R/A, respectively, Figure 1.3). At Day 30, maternal genotype influenced the 
prenatal survival; maternal genotype A presented a higher prenatal survival 




Figure 1.3. Interaction of fetal survival at Day 24 when the covariate implantation rate is 
included, for: group A/A (A[embryo]/A[mother]), group A/R (A[embryo]/R[mother]), group R/A 
(R[embryo]/A[mother]) and group R/R (R[embryo]/R[mother]). a,b values are statistically different 







2. Fetal and placental weight 
Both fetuses and placentas (fetal and maternal) were weighted at Day 14, 24 
and 30 (Figure 1.4).  
 
Figure 1.4. Fetal and placental (fetal and maternal) weights at Day 14, 24 and 30 of 
gestation.  A: Fetal weight for embryonic genotype effect; B: Fetal weight for maternal 
genotype effect; C: Fetal placenta weight for embryonic genotype effect; D: Fetal 
placenta weight for maternal genotype effect; E: Maternal placenta weight for 
embryonic genotype effect; F: Maternal placenta weight for maternal genotype 






Fetal weight at Day 14 was affected by both embryonic and maternal 
genotypes (Figure 1.4 A and B, respectively). Specifically, the interaction 
showed that group A/A has higher weight, while group R/R showed lower 
weight (0.29 ± 0.01 g vs. 0.19 ± 0.01 g, respectively, Figure 1.5). However, fetal 
weight at Day 24 did not vary between the embryonic and maternal genotype 
(Figure 1.4 A and B). At Day 30 foetus weight was almost significantly affected 
by the embryonic genotype (p-value=0.054), being higher for embryonic 
genotype R (53.40 ± 1.74 g and 48.50 ± 1.81 g, for embryonic genotype R and 
A, respectively, Figure 1.4 A). 
 
 
Figure 1.5. Interaction of fetal weight at Day 14 for: group A/A (A[embryo]/A[mother]), group 
A/R (A[embryo]/R[mother]), group R/A (R[embryo]/A[mother]) and group R/R (R[embryo]/R[mother]). 
a,b,c values are statistically different (p-value < 0.05). 
 
When maternal placental weight was compared, we did not observe 
differences at Day 14 (Figure 1.4 C, D), but when the number of implanted 





being higher for maternal genotype R (1.24 ± 0.05 g vs. 1.04 ± 0.05 g, genotype 
R and line A, respectively, Figure 6). However, at Day 24 maternal placental 
weight was similar for the embryonic and maternal genotype (Figure 1.4 C and 
D). Conversely, maternal placental weight presented differences for the 
embryonic and maternal genotype at Day 30 (Figure 1.4 C and D), being 
heavier for embryonic and maternal genotype R (1.39 ± 0.05 g and 1.52 ± 0.05 
g, respectively) than for genotypes A (1.21 ± 0.05 g and 1.45 ± 0.05 g, for 
embryonic and maternal genotypes, respectively). Nevertheless, the 
interaction between embryonic and maternal genotype was not significant. 
Respect to the fetal placental weight at Day 14 was similar for embryonic and 
maternal genotypes. However, at Day 24, the weight was affected by both 
embryo and maternal genotype, being higher for the group R/R (3.92 ± 0.12 g 
vs. 3.23 ± 0.11 g, for group R/R and A/A, respectively, Figure 1.4 E and F). On the 
contrary, fetal placental weight at Day 30 did not present differences for the 
embryonic and maternal genotype (Figure 1.4 E and F). 
 
Figure 1.6. Interaction of fetal placenta weight at Day 24 for group A/A 
(A[embryo]/A[mother]), group A/R (A[embryo]/R[mother]), group R/A (R[embryo]/A[mother]) and group 





3. Effect of group (R/R and A/A) on fetal placental gene expression at Day 14 
and Day 24 
Limma analysis after normalization did not reveal any significant changes in 
gene expression, neither at Day 14 not at Day 24. A total of six genes 
represented on the microarray (VEGF, ERBB3, TGFB2, IGF1, ITGA1, INFG) were 
selected and tested using RT-PCR. These genes were selected because they 
represent likely important moments as embryo development, implantation 
events and placenta formation. According to microarray results, no significant 
differences were observed between groups neither at Day 14 not at Day 24 
(Figure 1.7 and 1.8, respectively). 
 
Figure 1.7. Relative expression of vascular endothelial growth factor (VEGF), Epidermal 
Growth Factor receptor 3 (eRBB3), Transforming Growth Factor-B2 (TGFB2), Insulin-like 
Growth Factor I (IGF1), Integrin alpha-I (ITGA1) and Interferon-gamma (IFNG) for 
validation of Day 14 fetal placentas microarray. Relative abundance values are shown 








Figure 1.8 Relative expression of vascular endothelial growth factor (VEGF), Epidermal 
Growth Factor receptor 3 (eRBB3), Transforming Growth Factor-B2 (TGFB2), Insulin-like 
Growth Factor I (IGF1), Integrin alpha-I (ITGA1) and Interferon-gamma (IFNG) for 
validation of Day 24 fetal placentas microarray. Relative abundance values are shown 
in arbitrary units (a.u), expressed by the mean value ± standard error means. 
 
4. Effect of maternal genotype on progesterone and IGF1 levels 
Progesterone plasma levels at Day 14, 21 and 28 of gestation were similar 
between maternal genotypes R and A, with higher levels at Day 14 and 
decreasing levels at days 21 and 28 of gestation (Figure 1.9 A). As well, plasma 
levels of IGF1 were not different between recipients of the different lines at Day 
14, 21 and 28, with lower levels at Day 14 and reaching higher levels at Day 21 







Figure 1.9. Effect of maternal genotype on progesterone and IGF1 serum levels at Day 
14, 21 and 28 of gestation. A: Progesterone levels; B: IGF1 levels. 
 
DISCUSSION 
Survival and fitness of offspring depend on complex systems of provisioning 
resources between parents and offspring, resulting in intricate coadaptations to 
variations in supply and demand (SenthamaraiKannan et al., 2011). In 
eutherian mammals, fetal growth and epigenetic preadaptive responses for 
birth depend on the proper function of the placenta, which acts as an 
interface between the mother and foetus. Many studies describing genetic 
differences in prenatal survival in polytocous species have been performed 
(Brien, 1986; Blasco et al., 1993; Argente et al., 2003; Holt et al., 2004; Mocé et 
al., 2004b; Foxcroft et al., 2006; Freking et al., 2007; Laborda et al., 2012; Vicente 
et al., 2012; 2013).  However, few studies have been done to elucidate how 
maternal genotype, embryonic genotype and their dialogue can modify 
survival rate over the course of pregnancy. To examine this, we studied the 
effect of embryonic and maternal genotype at different stages of pregnancy 
(Day 14, 24 and 30) by reciprocal transfers. The embryo transfer model that we 





two different maternal genotypes, which allows us to study the fetal and 
maternal genotype effects, (ii) the female rabbit has a uterus formed by two 
independent horns (each horn possess its own cervix) and it have advantages 
in identification of the offspring and (iii) laparoscopic embryo transfer is a non-
invasive and feasible technique. 
Our results show that at Day 14 the fetal survival was significantly regulated by 
the embryonic genotype but not the maternal genotype. This finding correlates 
with previous studies (Youngs et al., 1994; Ernst et al., 2000, in mouse, Ashworth 
et al,. 1990; Kaminski et al., 1996, in swine and Vicente et al., 2013 in rabbits). 
However, at Day 24, when the covariate implantation rate was included fetal 
and maternal genotype interaction was determined, while at Day 30 (last term 
of gestation) occurs a change and fetal survival was significantly regulated by 
the maternal genotype. Mocé et al. (2004b), working with rabbits divergently 
selected by high and low uterine capacity found an interaction between both 
genotypes at Day 28. These authors suggest that the embryonic genotype had 
an effect on fetal survival only in a favorable maternal genotype. These results 
are in agreement with those reported by Moler et al. (1981), who detected a 
recipient and recipient x donor interaction effect on survival in mice to term. In 
our case, we did not observe this effect at post-implantation stages. Maybe, 
the relevant differences in the selection criteria of lines used in this study would 
explain this discrepancy.  
In terms of fetal and placental weights, our results show that at Day 14 the fetal 
weights were significantly regulated by both maternal and embryonic 
genotypes. This findings correlates with previous studies that showed that 





weight (Pomp et al., 1989; SenthamaraiKannan et al., 2011). Yet our results 
suggest that embryonic genotype may also influence fetal weight after 
implantation, and the maternal placenta weight. When the pregnancy 
progresses (at Day 24), these effects of the influence of embryonic and 
maternal genotypes on fetal weights and the maternal placental weights were 
not observed. Nevertheless, at last term of gestation (Day 30), maternal 
genotype seems to take a role, increasing embryo mortality. Thus, at Day 30 
also appears an effect of maternal genotype, which indicates that the 
recipient endometrium also plays a relevant role at the last term of gestation. 
However, when we studied two endocrine factors highly related to the 
development and maintenance of the endometrium and to the mobilization of 
maternal resources for gestation, we did not observe differences between both 
maternal genotypes. Inspite of this, specifically, R/R presented higher maternal 
placental weight than the other groups, being group A/A the one with lowest 
maternal placental weight. This could be a sign of placentomegaly to ensure a 
sufficient fetal growth and survival in this environment as a consequence of 
either a potential restriction before a fast growth from foetuses genotype R or a 
lower functionality of placenta. 
As the placenta is an interface receiving signals from both mother and foetus 
and a platform for maternal-fetal interaction, we analyzed fetal-placental to 
evaluate the fetal genotype effects on prenatal survival analysis compared 
gene expression with an embryo transfer system using the two inbred lines (A/A 
and R/R). The fact that no differences were observed in gene expression in fetal 
placentas at both Day 14 and Day 24 of gestation was surprising, considering 





terms of prenatal survival, the vast majority of the studies indicated a strong 
maternal uterine genotype effect (inbred strains (Fekete, 1947; Baunack et al., 
1986), genetically selected lines (Brumby, 1960; Moore et al., 1970a,b; Aitken et 
al., 1977; Al-Murrani and Roberts, 1978; Moler et al., 1981), or cross-nursing and 
sib analysis studies (Cox et al., 1959; El-Oksh et al., 1967)). Our findings indicate 
that the influence of embryo and maternal genotypes on rabbit prenatal 
survival and growth seem to change over gestation.  
In conclusion, embryonic genotype seems to influence prenatal survival, but 
additionally, at last term of gestation maternal genotype can affect embryonic 
mortality. Moreover, at early gestation (Day 14), embryonic genotype has an 
effect on fetal weight, while both embryonic and maternal genotype affected 
placental weights at Day 24 and 30, respectively. These findings highlight the 
need to consider both maternal and embryonic genetic effects in the neonatal 
survival over the course of pregnancy.  
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